Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
Sponsor: Fondazione Italiana Linfomi - ETS
Summary
This is an observational, multicenter, prospective cohort study including patients treated with CAR-T in Italian centers. Patients eligible for enrollment in the study will be consecutively included in Italian FIL centers. A longitudinal survey will be carried out by collecting patients' data before starting CAR-T (T0) and after 6 (T1), 12 (T2) and 24 (T3) months after CAR-T infusion.
Official title: Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy: a Multicenter Observational Prospective Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-05
Completion Date
2029-05
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
Chimeric Antigen Receptor T-cells (CAR-T) therapy
Patients will be treated with CAR-T cell product as per routine clinical practice.
Locations (8)
SCDU Ematologia - AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Alessandria, Italy
Clinica di Ematologia, AOU Ospedali Riuniti
Ancona, Italy
USD-TMO Adulti - ASST Spedali Civili di Brescia
Brescia, Italy
Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello
Palermo, Italy
Ematologia - Grande Ospedale Metropolitano Bianchi Melacrino Morelli
Reggio Calabria, Italy
Ematologia - Università Cattolica S. Cuore
Roma, Italy
SC Ematologia - Ospedale "S.G. Moscati"
Taranto, Italy
SOC Clinica Ematologica - Azienda Sanitaria Universitaria Friuli Centrale (ASU FC)
Udine, Italy